Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

Similar articles for PubMed (Select 2733040)

1.

Moles and site-specific risk of nonfamilial cutaneous malignant melanoma in women.

Weinstock MA, Colditz GA, Willett WC, Stampfer MJ, Bronstein BR, Mihm MC Jr, Speizer FE.

J Natl Cancer Inst. 1989 Jun 21;81(12):948-52.

PMID:
2733040
2.

Self-reports of mole counts and cutaneous malignant melanoma in women: methodological issues and risk of disease.

Bain C, Colditz GA, Willett WC, Stampfer MJ, Green A, Bronstein BR, Mihm MC, Rosner B, Hennekens CH, Speizer FE.

Am J Epidemiol. 1988 Apr;127(4):703-12.

PMID:
3354537
3.
4.

The transformation rate of moles (melanocytic nevi) into cutaneous melanoma: a population-based estimate.

Tsao H, Bevona C, Goggins W, Quinn T.

Arch Dermatol. 2003 Mar;139(3):282-8.

PMID:
12622618
5.

Overall and site-specific risk of malignant melanoma associated with nevus counts at different body sites: a multicenter case-control study of the German Central Malignant-Melanoma Registry.

Rieger E, Soyer HP, Garbe C, Büttner P, Kofler R, Weiss J, Stocker U, Krüger S, Roser M, Weckbecker J, et al.

Int J Cancer. 1995 Aug 9;62(4):393-7.

PMID:
7635564
6.

Risk factors for melanoma by body site.

Cho E, Rosner BA, Colditz GA.

Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1241-4.

7.
8.

Frequency of moles as a key to melanoma incidence?

Rampen FH, van der Meeren HL, Boezeman JB.

J Am Acad Dermatol. 1986 Dec;15(6):1200-3.

PMID:
3492519
9.

Trends in cutaneous malignant melanoma in Denmark 1943-1982 by anatomic site.

Osterlind A, Engholm G, Jensen OM.

APMIS. 1988 Nov;96(11):953-63.

PMID:
3196476
10.

Risk factors for melanoma: site variation in minimal erythema dose.

Bataille V, Cook D, Cuzick J, Edwards R, Newton J, Swerdlow A.

Melanoma Res. 1992 Jul;2(2):83-6.

PMID:
1643434
11.

Reliability of interviewer and subject assessments of nevus counts in a study of melanoma.

Walter SD, Marrett LD, Hertzman C.

J Clin Epidemiol. 1991;44(7):633-40.

PMID:
2066743
12.

Incidence and evolution of moles and the relationship to malignant melanoma in eastern India.

Reddy CR, Yellama A, Satyanarayana BV, Sundareshwar B.

Int Surg. 1976 Sep;61(9):469-71.

PMID:
965185
13.

Frequency of moles in a defined population.

Cooke KR, Spears GF, Skegg DC.

J Epidemiol Community Health. 1985 Mar;39(1):48-52.

14.

Nevus density and melanoma risk in women: a pooled analysis to test the divergent pathway hypothesis.

Olsen CM, Zens MS, Stukel TA, Sacerdote C, Chang YM, Armstrong BK, Bataille V, Berwick M, Elwood JM, Holly EA, Kirkpatrick C, Mack T, Bishop JN, Østerlind A, Swerdlow AJ, Zanetti R, Green AC, Karagas MR, Whiteman DC.

Int J Cancer. 2009 Feb 15;124(4):937-44. doi: 10.1002/ijc.24011.

15.
16.

Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?

Skender-Kalnenas TM, English DR, Heenan PJ.

J Am Acad Dermatol. 1995 Dec;33(6):1000-7.

PMID:
7490345
17.

Trends in the incidence of malignant melanoma in Sweden, by anatomic site, 1960-1984.

Thörn M, Bergström R, Adami HO, Ringborg U.

Am J Epidemiol. 1990 Dec;132(6):1066-77.

PMID:
2260538
18.

Cutaneous melanoma in women: anatomic distribution in relation to sun exposure and phenotype.

Cress RD, Holly EA, Ahn DK, LeBoit PE, Sagebiel RW.

Cancer Epidemiol Biomarkers Prev. 1995 Dec;4(8):831-6.

19.

Malignant melanoma incidence in Connecticut (United States): time trends and age-period-cohort modeling by anatomic site.

Chen YT, Zheng T, Holford TR, Berwick M, Dubrow R.

Cancer Causes Control. 1994 Jul;5(4):341-50.

PMID:
8080946
20.

Melanocytic nevi and risk of cutaneous malignant melanoma in southern Spain.

Ródenas JM, Delgado-Rodríguez M, Farinas-Alvarez C, Herranz MT, Serrano S.

Am J Epidemiol. 1997 Jun 1;145(11):1020-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk